*Screening for Albuminuria at the first line for early identification of chronic kidney disease
- Conditions
- chronic kidney disease10029149
- Registration Number
- NL-OMON54293
- Lead Sponsor
- General Practitioners Research Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 112
Diabetes Mellitus (diagnosis or prescription for the disease based on the NHG
guidelines)
Adipositas (diagnosis)
Hypertension (diagnosis or prescription for the disease based on the NHG
guidelines)
Cardiovascular disease (diagnosis, specified in protocol section 4.2.2)
Lipid disorder (diagnosis or prescription for the disease based on the NHG
guidelines)
Age 45-80 years
Pregnancy
Inability to write or understand the informed consent form
Known normal (<3mg/mmol) albuminuria status within 18 months prior
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>1. Elevated albuminuria, defined as a urinary albumin creatinine ratio (UACR) >=<br /><br>3.0 mg/mmol.<br /><br>2. Average screening costs per subject that was identified as having elevated<br /><br>albuminuria. All costs considered are mentioned in chapter 8.1.1.</p><br>
- Secondary Outcome Measures
Name Time Method